Archive for September, 2016

Young Survival Coalition Expresses Concern About Overlooked Moonshot Recommedations

| September 30, 2016 | 0 Comments

I haven’t written much about the President’s Cancer Moonshot initiative recently and as much as I would like – perhaps because following some Blue Ribbon Panel recommendations and a large number of organizations and individuals expressing, in general, positive feedback among the cancer community, there hasn’t been a lot of news about next steps.  I […]

Continue Reading

Upcoming Digital Pathology Webinars: 3D Histology and Multiplex Analysis of Brightfield Images

| September 29, 2016 | 0 Comments

microDimensions is hosting two compact digital pathology webinars back to back on Oct 11th. The first session on “3D Histology” will show how to reconstruct 3D volumes from serial histological sections (brightfield or fluorescence), how to view and analyze them and how to perform volume measurements e.g. of tumors. The second session on “Multiplex Analysis […]

Continue Reading

Visiopharm Pushes the Technical Boundaries of WSI Viewers

| September 28, 2016 | 0 Comments

Ultra-fast slide navigation for any magnification on ultra HD monitors at a fair price. Visiopharm is proud to announce the release of our new Viewer — the fastest, most compatible whole slide image viewer on the market for digital pathology, which is also a key component of Visiopharm’s end-to-end digital pathology solution. This solution is […]

Continue Reading

Harriett

| September 27, 2016 | 0 Comments

Mrs. Goldsmith was in her late 30’s when I first met her at my middle school. She had an older daughter that was 1 year ahead of me and Mrs. Goldsmith volunteered quite a bit at the school. As a 7th grade school boy I was struck by her grace and also her sternness. Whether […]

Continue Reading

Digitizing Pathology? Don’t Create Another Silo

| September 26, 2016 | 1 Comment

Post courtesy of Simon Häger, Product Manager Sectra Digital Pathology Solution Pathology departments play a key role in cancer care, but are currently under enormous pressure and face great challenges. Over the past decade, pathology departments have not only been subject to increasing demands as a result of the growing number of cases, but have […]

Continue Reading

Indica Labs Advance Immuno-oncology Capabilities with Innovative Quantification of Multiplexed Chromogenic Immunohistochemistry

| September 23, 2016 | 0 Comments

Corrales, NM – Indica Labs, a leading provider of software for quantitative evaluation of digital pathology images, is pleased to announce the release of a new module for multiplex chromogenic IHC analysis using HALO™. The Multiplex IHC module can separate up to five stains simultaneously and analyze any subcellular compartment, nucleus, cytoplasm or membrane, making […]

Continue Reading

Pathology Visions 2016 Room Block Closes Today!

| September 23, 2016 | 0 Comments

Don’t forget to reserve your room for Pathology Visions 2016! The DPA has secured a discounted room rate for attendees of Pathology Visions 2016 at the Manchester Grand Hyatt. The Pathology Visions room block will close today – Friday, September 23, 2016. MANCHESTER GRAND HYATT 1 Market Place San Diego, CA 92101 (619) 232-1234 manchestergrand.hyatt.com Why Attend Pathology […]

Continue Reading

Check Out Vision24 from Leica Biosystems at CAP ’16

| September 20, 2016 | 0 Comments

Continue Reading

Case Study using HALO™ and STRATA™: Biomarkers of Anti-Tumor Immune Activity Associate with Survival in Melanoma

| September 19, 2016 | 0 Comments

Wednesday September 28th | 8 AM PDT | 11 AM EDT | 4 PM BST Presenters Dr. Tricia Cottrell, Johns Hopkins Medical School  Vlado Ovtcharov, Indica Labs PD-L1 expression in the tumor microenvironment can be both prognostic and predictive.  PD-L1 expression is often a marker of an ongoing CD8+ cytotoxic T-cell-mediated anti-tumor immune response, and thus, […]

Continue Reading

Optra Systems Wins Global Telepathology Enabling Technology Leadership Award

| September 14, 2016 | 0 Comments

OptraSCAN was recently recognized by Frost and Sullivan with a Global Telepathology Enabling Technology Leadership Award. And why shouldn’t they be recognized — I think they are hitting on one of the key market segments that is largely underserved in digital pathology — lower volume scanning at the desktop with a price point to match. […]

Continue Reading

Inspirata Acquires Precision Medicine Network, Inc. and the ‘Crosswalk’ Platform to Bridge the Gap Between Digital Pathology and Molecular Oncology

| September 13, 2016 | 0 Comments

“Crosswalk Insight™: Oncology” enhances Inspirata’s Digital Pathology Cockpit by providing access to Genomic Profiles, FDA-Approved Targeted Therapies, Immunotherapies and Clinical Trials to enable pathologists to make more precise diagnostic and therapeutic decisions. Tampa, FL, September 13, 2016 – Cancer diagnostics and digital pathology workflow solution provider Inspirata, Inc. announced today that it has acquired the assets […]

Continue Reading

Never Forget

| September 11, 2016 | 0 Comments

Continue Reading

Cancer Moonshot Panel Releases “Blue Ribbon” Recommendations

| September 9, 2016 | 0 Comments

Download PDF of Recommendations The Washington Post (9/7, McGinley) highlights a report released by a “blue-ribbon panel” of “top cancer researchers and patient advocates” as part of the White House’s cancer moonshot. The report recommends that cancer researchers and others adopt a list of 10 goals aimed at improving cancer research, cancer patient care, and related matters. Congressional Quarterly (9/7, […]

Continue Reading

Dismissiveness of “Pinktober” Starting Early

| September 9, 2016 | 0 Comments

Last Fall I wrote a couple of posts about the growing disenchantment with ‘Pinkification’ and ‘Pinktober’ referencing the all-out blitz during October to go “Pink” for breast bancer awareness and prevention.  In one of the pieces I mentioned by disenchantment with what happened a number of years ago I saw in clinical practice and last […]

Continue Reading